West Pharmaceutical Services — 8-K/A confirms full operational restoration

West Pharmaceutical Services (NYSE: WST) filed an 8-K/A amendment under SEC Item 1.05 on 2026-05-20 confirming full operational restoration across all manufacturing facilities, with the data investigation still ongoing. Closing the loop on the W20 disclosure: the manufacturing-line continuity risk this audience was tracking has resolved; the residual is the data-scope determination.